Erika M. Gaglione

Also affiliated with National Heart Lung and Blood Institute, University of Virginia

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccines”.

Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccines

Blood(2020)10.1182/blood.2020008758

N/A

7.9DataRank · unranked

141 citations

Mir A. Ali, Jeffrey I. Cohen, Xin Tian, Susan Soto, Inhye E. Ahn +9 more

Clinical and biological implications of target occupancy in CLL treated with the BTK inhibitor acalabrutinib

Blood(2020)10.1182/blood.2019003715

N/A

3.3DataRank · unranked

106 citations

Pia Nierman, Ellen K. Kendall, Jean Cheung, Michael Gulrajani, Sarah E. M. Herman +16 more

Pharmacodynamic Analysis of BTK Inhibition in Patients with Chronic Lymphocytic Leukemia Treated with Acalabrutinib

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3505

N/A

1.7DataRank · unranked

31 citations

Jean Cheung, Michael Gulrajani, Erika M. Gaglione, Pia Nierman, Ahmed Hamdy +8 more

CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3217

N/A

0.782DataRank · unranked

21 citations

Jonathan Chen, Erika M. Gaglione, Chingiz Underbayev, Pamela L. Tuma, Xin Tian +12 more

Overcoming Acquired Epigenetic Resistance to BTK Inhibitors

Blood Cancer Discovery(2021)10.1158/2643-3230.bcd-21-0063

N/A

0.619DataRank · unranked

61 citations

James D. Phelan, James Q. Wang, Dawei Huang, George W. Wright, Monica Kasbekar +26 more

Patient-derived Siglec-6-targeting antibodies engineered for T-cell recruitment have potential therapeutic utility in chronic lymphocytic leukemia

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2022-004850

N/A

0.474DataRank · unranked

10 citations

Maissa Mhibik, Junpeng Qi, Haiyong Peng, Chang Jing, Erika M. Gaglione +9 more

Select Antitumor Cytotoxic CD8+ T Clonotypes Expand in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4894

N/A

0.385DataRank · unranked

12 citations

Sivasubramanian Baskar, Erika M. Gaglione, Keyvan Keyvanfar, Inhye E. Ahn, Adrian Wiestner +2 more

Risk-adapted, ofatumumab-based chemoimmunotherapy and consolidation in treatment-naïve chronic lymphocytic leukemia: a phase 2 study

Leukemia & lymphoma/Leukemia and lymphoma(2021)10.1080/10428194.2021.1888379

N/A

0.286DataRank · unranked

4 citations

Clifton C. Mo, Erika M. Gaglione, Constance M. Yuan, Maryalice Stetler‐Stevenson, Xin Tian +20 more

Cytotoxicity of the CD3×CD20 bispecific antibody epcoritamab in CLL is increased by concurrent BTK or BCL-2 targeting

Blood Advances(2023)10.1182/bloodadvances.2022009517

N/A

0DataRank · unranked

40 citations

Erika M. Gaglione, David Eik, John H. Herrick, J. Le, Inhye E. Ahn +11 more

A phase II study of ibrutinib and short‐course fludarabine in previously untreated patients with chronic lymphocytic leukemia

American Journal of Hematology(2020)10.1002/ajh.25968

N/A

0DataRank · unranked

5 citations

Xin Tian, Shakuntala Rampertaap, Rui Mu, Susan Soto, Jeanine Superata +12 more